Latest News & Features
Biotechnology
The UK Competition and Markets Authority is investigating Essential Pharma over suspicions that the pharmaceutical company contravened competition law by proposing to withdraw the supply of Priadel, a lithium-based medication for bipolar disease. 30 November 2020
Asia-Pacific
The Federal Court of Australia has granted Pfizer subsidiary Wyeth’s bid for an injunction against Merck Sharp Dohme in a dispute over vaccine patents. 30 November 2020
Europe
Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility. 30 November 2020
Big Pharma
The European Commission has fined Teva and its subsidiary Cephalon €60.5 million for agreeing to delay a cheaper generic version of sleep disorder drug modafinil. 27 November 2020
Americas
The US Department of Health and Human Services will reveal more information regarding its licensing of IP to private companies for drug development, it has confirmed in a letter to a congressional watchdog. 26 November 2020
article
The partner at Arnold & Porter Kaye Scholer on second medical use patents, career goals after parenthood and the joy of being a “failed scientist” in IP. 26 November 2020
Generics
The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said. 25 November 2020
Americas
Philips was not anti-competitive when it refused a medical equipment maintenance company access to its software for ultrasound machines but did misuse its copyright, the US District Court for the Western District of Washington has ruled. 24 November 2020
Big Pharma
The Delhi High Court has refused to grant AstraZeneca an injunction against the manufacture and sale of dapagliflozin by a group of India-based pharmaceutical companies. 24 November 2020
Americas
The US Court of Appeals for the Federal Circuit rejected GlaxoSmithKline’s challenge of a $107 million verdict which found the drugmaker had infringed a dry-powder inhaler patent. 20 November 2020